<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon's syndrome</z:e> is a complex <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> disorder due to mutations in fibroblast growth factor receptor (FGFR) type 2 </plain></SENT>
<SENT sid="1" pm="."><plain>We report a female patient with <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon's syndrome</z:e> associated with <z:hpo ids='HP_0000956'>acanthosis nigricans</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The molecular abnormality in this patient is a point mutation (Ala391Glu) in the transmembrane domain of another FGFR (type 3), which is very close to the mutation (Gly380Arg) most frequently observed in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000956'>Acanthosis nigricans</z:hpo> is an emerging disorder </plain></SENT>
<SENT sid="4" pm="."><plain>Its clinical features and molecular findings differ from those of isolated <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon's syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>These data are very useful when molecular tests are required for prenatal diagnosis </plain></SENT>
</text></document>